ArticleGynecologic oncology reports2026

Refractory ultra-high-risk Choriocarcinoma achieving complete response to intensive multi-agent and intrathecal chemotherapy and anti-PD-L1 therapy.

Laura Venegas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.